Trial Profile
Use of Basiliximab to prevent acute rejection in patients undergoing renal transplantation.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Mar 2015
Price :
$35
*
At a glance
- Drugs Basiliximab (Primary)
- Indications Renal transplant rejection
- Focus Pharmacodynamics
- 14 Mar 2015 New trial record